Sponsors (26)
The bill increases timely, privacy-protected access to contraception and strengthens enforcement for consumers, but does so by imposing new compliance obligations, fines, and litigation risks on pharmacies and creating potential conflicts with conscience claims and insurance/taxpayer concerns.
Millions of people who can become pregnant gain faster, more reliable access to contraception because the bill documents OTC approvals and requires pharmacies to keep in-stock supplies or provide prompt referrals/expedited ordering.
Women and people who can become pregnant keep stronger reproductive autonomy and privacy protections (reducing intimidation, deception, and confidentiality breaches), supporting their ability to pursue education and employment.
Insured individuals who receive contraceptive coverage benefit from lower out-of-pocket costs — historic ACA coverage reached tens of millions and produced large aggregate savings — highlighting direct consumer savings when coverage is maintained.
Pharmacies — especially small or independent ones — face new compliance costs, potential daily fines, inventory and logistics changes, and increased litigation risk, which could raise operating costs and be passed on to consumers or reduce local access.
Pharmacists, pharmacy employees, and some state regulators face increased legal exposure and workplace risk because access requirements can conflict with conscience or professional-judgment claims, inviting disputes and lawsuits.
Emphasizing ACA coverage and historic savings could heighten political pressure to maintain or expand contraceptive coverage mandates, raising concerns about higher insurance premiums or taxpayer costs for those opposed to expanded mandates.
Based on analysis of 3 sections of legislative text.
Requires pharmacies receiving contraceptives in interstate commerce to immediately dispense in-stock contraceptives or promptly refer/order them, bans obstructive conduct, allows narrow refusals, and preserves stronger state protections.
Introduced July 16, 2025 by Cory Anthony Booker · Last progress July 16, 2025
Requires pharmacies that receive FDA-approved contraceptives or related products in interstate commerce to give customers prompt access: if an item is in stock it must be dispensed immediately; if not, the pharmacy must either refer/transfer the prescription to a pharmacy with the item or order it quickly and notify the customer. The bill also bars certain obstructive conduct (intimidation, deception, confidentiality breaches, refusals to return prescriptions), allows limited, defined refusals (illegal dispensing, inability to pay, clinical judgment), preserves stronger state protections, and restricts use of the Religious Freedom Restoration Act as a defense against these requirements.